Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...

Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...

The tepid reception to Venture Global's ambitious valuation target shows companies need to set realistic expectations when ...

Smithfield Foods could be one of the year's biggest U.S. initial public offerings, with the pork producer planning to raise as much as $940 million as it returns to the stock market.

Laxmi Dental shares will be listed on both the stock exchanges, BSE and NSE. Laxmi Dental IPO GMP and experts signal strong ...

Laxmi Dental shares are set to list today at 10 AM with analysts anticipating a strong premium over the issue price, ...

The startups are the fourth and fifth drugmakers to file for initial stock sales since late December — the most IPO activity ...

Analysts anticipate a premium listing of up to 40 percent, recommending investors to hold their positions for the long term.

Post the premium listing, shares of Stallion India Fluorochemicals closed at its upper circuit on the NSE and BSE at ₹126 and ...

Guangdong Hongshi Laser Technology Co., Ltd. (HSG Laser) has failed to complete its initial public offering (IPO), marking a ...

The IPO was expected to be the first blockbuster listing of 2025, as well as a litmus test for the appetite for energy ...

ServiceTitan has made its debut on the NASDAQ — see what that means for the HVAC contractors and what opportunities this move ...